MLTXHealthcareSmall-Cap
MoonLake Immunotherapeutics Insider Trading Activity
Every SEC Form 4 insider transaction reported for MoonLake Immunotherapeutics (MLTX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are MLTX insiders buying or selling?
MoonLake Immunotherapeutics insiders reported 9 open-market buys ($134.8M) and 24 sells ($266.0M) across 33 Form 4 filings — a net selling position of $131.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 20, 2026)
Total Form 4 filings
33
SEC EDGAR
Insider filers
8
Insider buys (9)
$134.8M
Insider sells (24)
$266.0M
Insider sentiment
Net sellingNet insider flow of $131.2M in net selling.
Recent MLTX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Kristian Reich | Chief Scientific Officer | Sale | 16.1K | $20.01 | $322.3K |
| Jul 13, 2026 | da Silva Jorge Santos | Chief Executive Officer | Sale | 102.2K | $20.02 | $2.0M |
| Jul 2, 2026 | da Silva Jorge Santos | Chief Executive Officer | Sale | 47.8K | $20.03 | $956.9K |
| Jun 23, 2026 | Matthias Bodenstedt | Chief Financial Officer | Sale | 39.1K | $22.04 | $862.2K |
| Jun 18, 2026 | Matthias Bodenstedt | Chief Financial Officer | Sale | 17.9K | $19.67 | $351.6K |
| Jun 17, 2026 | Kristian Reich | Chief Scientific Officer | Sale | 150.0K | $19.01 | $2.9M |
| May 13, 2026 | Matthias Bodenstedt | Chief Financial Officer | Sale | 13.7K | $20.02 | $273.3K |
| Apr 16, 2026 | Matthias Bodenstedt | Chief Financial Officer | Sale | 2.4K | $19.56 | $47.5K |
| Apr 14, 2026 | da Silva Jorge Santos | Chief Executive Officer | Sale | 150.0K | $18.35 | $2.8M |
| Apr 10, 2026 | Matthias Bodenstedt | Chief Financial Officer | Sale | 87.8K | $18.95 | $1.7M |
| Apr 2, 2026 | Mark N Lampert | Director, 10% Owner | Sale | 3.8M | $16.79 | $63.0M |
| Dec 10, 2025 | da Silva Jorge Santos | Chief Executive Officer | Sale | 200.0K | $14.87 | $3.0M |
| Dec 10, 2025 | Kristian Reich | Chief Scientific Officer | Sale | 202.9K | $14.85 | $3.0M |
| Oct 9, 2025 | Matthias Bodenstedt | Chief Financial Officer | Purchase | 10.9K | $9.09 | $98.8K |
| Oct 1, 2025 | Bihua Chen | Other | Sale | 6.5M | $7.21 | $46.9M |
| Jul 7, 2025 | Catherine Moukheibir | Director | Sale | 23.5K | $48.79 | $1.1M |
| Oct 8, 2024 | Mark N Lampert | Director, 10% Owner | Sale | 2.0M | $50.00 | $100.0M |
| Oct 8, 2024 | Simon Sturge | Director | Sale | 171.0K | $53.72 | $9.2M |
| Mar 1, 2024 | da Silva Jorge Santos | Chief Executive Officer | Sale | 123.6K | $55.03 | $6.8M |
| Mar 1, 2024 | Kristian Reich | Chief Scientific Officer | Sale | 118.9K | $55.00 | $6.5M |
| Feb 23, 2024 | da Silva Jorge Santos | Chief Executive Officer | Sale | 1.1K | $55.27 | $62.2K |
| Feb 22, 2024 | Kristian Reich | Chief Scientific Officer | Sale | 21.1K | $57.33 | $1.2M |
| Feb 20, 2024 | da Silva Jorge Santos | Chief Executive Officer | Sale | 60.0K | $59.26 | $3.6M |
| Feb 16, 2024 | Kristian Reich | Chief Scientific Officer | Sale | 60.0K | $60.91 | $3.7M |
| Dec 21, 2023 | Matthias Bodenstedt | Chief Financial Officer | Sale | 100.0K | $59.17 | $5.9M |
Showing the 25 most recent of 33 Form 4 filings for MoonLake Immunotherapeutics.
Most active MLTX insiders
- Bihua Chen8 filings
- da Silva Jorge Santos7 filings
- Matthias Bodenstedt7 filings
- Kristian Reich6 filings
- Mark N Lampert2 filings
Ask anything about MLTX insider activity
Use Trabud's AI agent to query MoonLake Immunotherapeutics's Form 4 history in plain English — "Show me MLTX CEO purchases this year" or compare it against any other ticker.
Open the AI agentMLTX insider trading FAQ
Are MoonLake Immunotherapeutics insiders buying or selling?
Across 33 SEC Form 4 filings, MoonLake Immunotherapeutics (MLTX) insiders reported 9 open-market purchases totaling $134.8M and 24 sales totaling $266.0M. That is a net selling position of $131.2M.
How many insiders trade MLTX stock?
8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for MoonLake Immunotherapeutics. The most recent filing was accepted on Jul 20, 2026.
Where does Trabud get MLTX insider trading data?
All MLTX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.